Cancer Immunotherapy 101 with Dr. Ellen Puré

Dr. Ellen Puré of the University of Pennsylvania explores how our immune system works, breaks down into basic concepts the complex science underlying immunotherapy, describes the different types of immunotherapy, and discusses potential side effects and benefits patients can anticipate. #CRIsummit #immunotherapy https://summit.cancerresearch.org/ 00:00- Tamron Hall introduces Dr. Ellen Puré 00:45- Dr. Puré discusses immunotherapy and how it works 27:45- Tamron Hall leads a Q&A session from the audience with Dr. Puré Immunotherapy continues to transform cancer treatment across several cancer types and shows incredible promise for the future of all cancer care. But what is immunotherapy and how does it work? How is immunotherapy different from other types of cancer treatment? https://www.cancerresearch.org/immuno... Dr. Puré answers questions from the audience: If given the choice between chemotherapy and immunotherapy, what should I consider? What is the difference between chemotherapy and immunotherapy? I am about to begin a checkpoint inhibitor immunotherapy. What are common side effects? This summer was the one-year anniversary of my CAR T cell infusion for non-Hodgkin lymphoma. - While I feel well and am considered cancer-free, I am worried about the cancer returning: Does immunotherapy provide lasting results? I have been receiving immunotherapy for nearly two years for melanoma. How long do I need to be on immunotherapy—when is treatment complete? Dr. Ellen Puré is the Grace Lansing Lambert Professor of Biomedical Science and chair of the department of biomedical sciences at the University of Pennsylvania School of Veterinary Medicine in Philadelphia. She is an associate director of the CRI Scientific Advisory Council and chairwoman of the CRI Postdoctoral Fellowship Review Committee. Her research focuses on the cellular and molecular basis of inflammation and fibrosis. https://www.cancerresearch.org/en-us/... The 2021 CRI Virtual Immunotherapy Patient Summit is part of the Cancer Research Institute's Answer to Cancer Patient Education Program. It was offered free of charge, connecting cancer patients and caregivers with scientific and medical experts. This year’s Summit highlighted the growing implications of immunotherapy for more than 10 cancer types, provided education on the basics of immunotherapy and how clinical trials work, and addressed cancer care disparities. https://www.cancerresearch.org/en-us/... Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.